✦ LIBER ✦

0130 Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population

✍ Scribed by A. Howell; J. Forbes; J. Cuzick

Book ID: 114316268
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 52 KB
Volume: 18
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(09)70162-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

Pharmacokinetics of anastrozole and tamo

Pharmacokinetics of anastrozole and tamoxifen alone and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial

✍ Trialists' Group, T.A. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 77 KB

Fewer endometrial abnormalities with ana

Fewer endometrial abnormalities with anastrozole than tamoxifen: Endometrial subprotocol results from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) early breast cancer trial in postmenopausal patients

✍ Sean Duffy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 196 KB

P115 Fewer gynaecological adverse events

P115 Fewer gynaecological adverse events (AEs), gynaecological interventions, endometrial changes and abnormalities with anastrozole than with tamoxifen: findings from the ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial

✍ W. Distle 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P128 Safety and tolerability data from t

P128 Safety and tolerability data from the ATAC(‘arimidex’, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment

✍ Wolfgang Distler 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB